Veradigm | MDRX - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Alcidion AUD 23.27M 565K 2025-12
Ambu A/S DKK 1.41B 12M 2026-09
Amplifon EUR 534.52M 8.4M 2026-09
Cardinal Health USD -3.03B 65.88B 2026-09
Centene USD 22.21B 355M 2026-09
Charles River Laboratories USD 3.23B 387.38M 2026-09
Cigna USD 43.38B 763M 2026-09
Coloplast 5.19B 185M 2025-12
Convatec Group USD 1B 518M 2024-12
CVS Health USD 104.83B 5.47B 2026-09
Diasorin EUR 245.56M 14.56M 2026-06
Elevance Health USD 49.28B 4.39B 2026-09
General Electric Aerospace USD 17.52B 118M 2026-09
Gulf Medical Proj AED 168.72M 14.25M 2026-03
Humana USD 18.83B 20.68B 2026-09
IQVIA Holdings USD 3.82B 2.05B 2026-09
Laboratory Of America USD 3.39B 117.6M 2026-09
Max Healthcare Institute Limited 19.95B 959.7M 2026-09
Maximus USD 1.74B 43.59M 2026-06
McKesson USD 109.27B 5.31B 2026-09
Med Life RON 809.23M 61.36M 2026-03
Molina Healthcare USD 10.98B 259M 2026-09
Omnicell USD 292.92M 17.03M 2026-09
Oriola-kd EUR 46.5M 1.1M 2026-09
Owens Minor USD -568.23M 17.29M 2026-09
Quest Diagnostics USD 2.62B 34M 2026-09
Rede D'or Sao Luiz BRL 11.66B 232.07M 2026-06
Siemens Healthineers EUR 5.94B 1.12B 2026-09
Sonova Holding CHF 1.52B 59.9M 2025-12
Supermax Corporation Bhd MYR 187.31M 19.71M 2026-06
UnitedHealth USD 106.35B 2.31B 2026-09
Veeva Systems USD 652.94M 43.11M 2026-06
Veradigm USD 188M 61.08M 2022-12
Xerox USD -683M 1.01B 2026-09